Next Article in Journal
Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update
Next Article in Special Issue
mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus
Previous Article in Journal
Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10
Previous Article in Special Issue
1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages
 
 
Article

Article Versions Notes

Cancers 2020, 12(4), 789; https://doi.org/10.3390/cancers12040789
Action Date Notes Link
article xml file uploaded 26 March 2020 09:57 CET Original file -
article pdf uploaded. 26 March 2020 09:57 CET Version of Record https://www.mdpi.com/2072-6694/12/4/789/pdf-vor
article xml file uploaded 31 March 2020 11:41 CEST Update -
article xml uploaded. 31 March 2020 11:41 CEST Update https://www.mdpi.com/2072-6694/12/4/789/xml
article pdf uploaded. 31 March 2020 11:41 CEST Updated version of record https://www.mdpi.com/2072-6694/12/4/789/pdf
article html file updated 31 March 2020 11:43 CEST Original file -
article html file updated 21 July 2022 00:01 CEST Update https://www.mdpi.com/2072-6694/12/4/789/html
Back to TopTop